Source:http://linkedlifedata.com/resource/pubmed/id/12906935
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2003-8-8
|
pubmed:abstractText |
To gain insight into the spatial nature of the androstenedione (AD) binding (active) site of aromatase in relation to the catalytic function of the enzyme, we synthesized 2,2-dimethylAD (4), 2beta- and 2alpha-methylADs (5 and 6), 19-oxygenated derivatives of compounds 4 and 6, and 2-methyleneAD (17), and we then tested their inhibitory activity as well as their aromatase reaction (aromatization for 2-methyl and 2-methylene analogs or 19-oxygenation for 2,2-dimethyl steroids) with human placental aromatase. 2-Methyl and 2-methylene steroids 5, 6, and 17 were good competitive inhibitors of aromatase (K(i)=22-68nM), but less effective compared to the 2,2-dimethyl analog 4 (K(i)=8.8nM), indicating that a combination of 2beta- and 2alpha-methyl moieties is essential for the formation of a thermodynamically stable inhibitor-aromatase complex. A series of 2alpha-methyl steroids were good substrates for aromatase, whereas 2beta-methyl steroid 5 was an extremely poor substrate, and a series of 2,2-dimethyl steroids did not serve as substrate, suggesting that a 2beta-methyl moiety of the 2,2-dimethyl and 2beta-methyl steroids would prevent the aromatase reaction probably due to steric hindrance in each case. The 2-methylene compound 17 was also aromatized to produce 2-methylestrogen with a low conversion rate where the 1,4-diene structure may have been created before the C(10)-C(19) bond cleavage. Kinetic analysis of the aromatization of androgens revealed that a good substrate was not essentially a good inhibitor for aromatase.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0039-128X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
68
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
503-13
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12906935-Androstenedione,
pubmed-meshheading:12906935-Aromatase,
pubmed-meshheading:12906935-Binding Sites,
pubmed-meshheading:12906935-Catalysis,
pubmed-meshheading:12906935-Female,
pubmed-meshheading:12906935-Humans,
pubmed-meshheading:12906935-Kinetics,
pubmed-meshheading:12906935-Microsomes,
pubmed-meshheading:12906935-Oxidation-Reduction,
pubmed-meshheading:12906935-Placenta,
pubmed-meshheading:12906935-Steroids,
pubmed-meshheading:12906935-Structure-Activity Relationship,
pubmed-meshheading:12906935-Substrate Specificity
|
pubmed:year |
2003
|
pubmed:articleTitle |
Probing the active site of aromatase with 2-methyl-substituted androstenedione analogs.
|
pubmed:affiliation |
Tohoku Pharmaceutical University, 4-1 Komatsushima-4-chome, Aobaku, 981-8558, Sendai, Japan. numazawa@tohoku-pharm.ac.jp
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|